IMMUNOQURE AG
ImmunoQure AG rare natural antibodies derived from patients for patients. ImmunoQure AG is a young biotech company spearheading the research and development of human-derived antibodies (HD-MABs) for the treatment of human diseases. Through our unique access to rare patient populations, we are able to identify patients harboring naturally optimized antibodies against key drug targets that are involved in preventing a number of human diseases.
IMMUNOQURE AG
Industry:
Biotechnology Health Care Medical
Address:
Martinsried, Bayern, Germany
Country:
Germany
Website Url:
http://www.immunoqure.de
Status:
Active
Contact:
+49089416141353
Email Addresses:
[email protected]
Technology used in webpage:
SPF
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Inatherys
Inatherys is a biotechnology company developping monoclonal antibodies for the treatment of cancers and inflammatory diseases.
Marinomed
Marinomed is a biopharmaceutical company that develops innovative anti-viral and immunological treatments.
Pepsyn
Pepsyn is a biotechnology company, develops and markets milk-derived peptides for cosmetic.
Official Site Inspections
http://www.immunoqure.de
- Host name: ispconf05.rhein-it.de
- IP address: 80.252.111.87
- Location: Hamburg Germany
- Latitude: 53.5512
- Longitude: 9.9662
- Timezone: Europe/Berlin
- Postal: 20359
More informations about "ImmunoQure AG"
ImmunoQure AG - Crunchbase Company Profile & Funding
ImmunoQure AG rare natural antibodies derived from patients for patients. ImmunoQure AG is a young biotech company spearheading the research and development of human-derived …See details»
ImmunoQure Company Profile 2025: Valuation, Funding
ImmunoQure General Information Description. Developer of patient-selected antibodies intended to offer treatment of inflammatory and autoimmune diseases. The company's autoantibodies …See details»
ImmunoQure AG - Martinsried, Germany - bionity.com
ImmunoQure AG is a young biotech company spearheading the research and development of human-derived antibodies (HD-MABs) for the treatment of human diseases. Through our …See details»
ImmunoQure AG Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ImmunoQure AG of Düsseldorf, Nordrhein-Westfalen. Get the latest business insights from Dun & …See details»
ImmunoQure AG - VentureRadar
ImmunoQure AG is a young biotech company spearheading the research & development of human-derived autoantibodies for the treatment of human diseases. Through our unique …See details»
ImmunoQure AG - Dun & Bradstreet
Finden Sie Unternehmensinformationen, Mitbewerber, Ansprechpersonen und Finanzdaten für ImmunoQure AG in Düsseldorf, Nordrhein-Westfalen. Erhalten Sie die neuesten …See details»
ImmunoQure AG, Düsseldorf - North Data
ImmunoQure AG, Düsseldorf, Amtsgericht München HRB 192992: Patente, Netzwerk, WirtschaftsinfosSee details»
ImmunoQure Research AG - life-sciences-europe.com
Jun 26, 2013 Upcoming Events. Biotech Showcase 2025 San Francisco; J.P. Morgan 43rd Annual Healthcare Conference 2025 San Francisco; Global Forum for Food and Agriculture …See details»
ImmunoQure AG - Crunchbase
ImmunoQure AG, Enzyvant Sciences, Inatherys, Marinomed, Metabolyzer, and Mosaic Biomedicals are part of the biotechnology sector. Enzyvant Sciences, Inatherys, and Mosaic Biomedicals focus on developing antibodies for disease …See details»
ImmunoQure AG - Tech Stack, Apps, Patents & Trademarks
ImmunoQure AG is a biotech company developing human-derived antibodies for disease treatment.See details»
ImmunoQure | Biotechnology - The Pharmaletter
Immunoqure is a German biotech company that claims to be spearheading the development of human-derived antibodies. The company's goal is to become a strong alliance partner for …See details»
ImmunoQure AG - VentureRadar
ImmunoQure AG VentureRadar profile. Find out more about ImmunoQure AG including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
ImmunoQure And Memo Therapeutics Collaborate To Biobank …
Nov 7, 2019 ImmunoQure AG, a biotechnology company focused on the development of autoantibodies as therapeutics to treat human diseases and Memo Therapeutics AG, a …See details»
ImmunoQure Research AG - Zürich, Switzerland - bionity.com
ImmunoQure AG is a young biotech company focused on generating novel antibody-based therapeutics for the treatment of inflammation and autoimmune diseases.See details»
immunoqure.com
Immunoqure.comSee details»
Strategic Partnership for the Development of an Interferon-alpha …
Feb 14, 2018 ImmunoQure, a biotech company focused on the research and development of human autoantibodies as therapeutics for the treatment of common human diseases and the …See details»
ImmunoQure AG Announces Publication in Cell of Naturally …
- ImmunoQure AG, a German biotechnology company focused on the development of autoantibodies as therapeutics to treat common human diseases today announced the …See details»
IQ-003 - Drug Targets, Indications, Patents - Synapse - Patsnap
IQ-003, Initially developed by Immunoqure AG, Now, its global highest R&D status is Preclinical, Therapeutic Areas: Immune System Diseases,Other Diseases, Active Indication: Autoimmune …See details»
Research programme: autoantibody therapeutics - ImmunoQure AG
Human derived autoantibody therapeutics are being developed by ImmunoQure AG, for the treatment of autoimmune disorders. The company is focussed on theSee details»
Immunocore Holdings plc (IMCR)
Jan 2, 2025 We want to radically improve outcomes for patients with cancer, infectious diseases, and autoimmune diseases, by pioneering and delivering transformative immunomodulating …See details»